As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.
Read full story
Research news
Wednesday, June 14, 2023 Congratulations Dr. Dennis Ko!
Dr. Ko has been appointment as Vice Chair of the Institute Advisory Board, CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH).
Read full story
Dr. Ko has been appointment as Vice Chair of the Institute Advisory Board, CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH).
Read full story
Monday, June 5, 2023 Drug prolongs time before brain tumour grows back
As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.
Read full story
As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.
Read full story
Tuesday, May 30, 2023 Sunnybrook student-run conference highlights research excellence
Congratulations to Vivian Feng, Martin Profant, Bhawani Jain and Yejin Kang, who all were awarded prizes at this year's conference.
Read full story
Congratulations to Vivian Feng, Martin Profant, Bhawani Jain and Yejin Kang, who all were awarded prizes at this year's conference.
Read full story
Friday, May 26, 2023 How a polio epidemic led to the invention of intensive care
In this Q & A, critical care physician and researcher Dr. Hannah Wunsch discusses polio and the origin story of intensive care.
Read full story
In this Q & A, critical care physician and researcher Dr. Hannah Wunsch discusses polio and the origin story of intensive care.
Read full story
Wednesday, May 24, 2023 Sunnybrook scientists awarded CIHR funding to research mpox and other zoonotic diseases
CIHR’s Centre for Research on Pandemic Preparedness and Health Emergencies is providing funding for eleven of the mpox projects, while the HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Research Initiative is funding two projects.
Read full story
CIHR’s Centre for Research on Pandemic Preparedness and Health Emergencies is providing funding for eleven of the mpox projects, while the HIV/AIDS and Sexually Transmitted and Blood Borne Infections (STBBI) Research Initiative is funding two projects.
Read full story
